Neurosteroids and GABAergic signaling in health and disease
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Endogenous neurosteroids such as allopregnanolone, allotetrahydrodeoxycorticosterone, and androstanediol are synthesized either de novo in the brain from cholesterol or are generated from the local metabolism of peripherally derived progesterone or corticosterone. Fluctuations in neurosteroid concentrations are important in the regulation of a number of physiological responses including anxiety and stress, reproductive, and sexual behaviors. These effects are mediated in part by the direct binding of neurosteroids to γ-aminobutyric acid type-A receptors (GABA A Rs), resulting in the potentiation of GABA A R-mediated currents. Extrasynaptic GABA A Rs containing the δ subunit, which contribute to the tonic conductance, are particularly sensitive to low nanomolar concentrations of neurosteroids and are likely their preferential target. Considering the large charge transfer generated by these persistently open channels, even subtle changes in neurosteroid concentrations can have a major impact on neuronal excitability. Consequently, aberrant levels of neurosteroids have been implicated in numerous disorders, including, but not limited to, anxiety, neurodegenerative diseases, alcohol abuse, epilepsy, and depression. Here we review the modulation of GABA A R by neurosteroids and the consequences for health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neural regulation of endocrine and autonomic stress responses
Ulrich-Lai, Y. M., & Herman, J. P. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2647 · Cited by 3,318
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 16×
“The basal THDOC concentration in the plasma of rats (26, 27) and humans (28, 29) is approximately ≤ 5 n m at rest.”
InfluentialVariations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081 · cited 4×
“Generally, an increase in the tonic conductance will reduce the input resistance narrowing the temporal and spatial integration of synaptic events and increasing the amount of excitatory input required to generate an action potential (54, 88) .”
InfluentialNeurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159 · cited 2×
“Neurosteroids are modulators of aminobutyric acid type A receptors (GABA A Rs) and can induce analgesic, anxiolytic, sedative, anesthetic, and anticonvulsant effects (4, 5) .”
Purdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Neurosteroids: biosynthesis and function of these novel neuromodulators
Compagnone, N. A., & Mellon, S. H. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0188 · Cited by 820 · cited 1×
“Allopregnanolone and THDOC can be synthesized from cholesterol by a series of steroidogenic enzymes [for reviews, see (2, 5, 17, 18) ] (Figure 1).”
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752 · cited 2×
“Yet, at higher micromolar concentrations, neurosteroids directly activate the receptor in the absence of GABA (63) .”
Neurosteroids: biochemistry and clinical significance
Mellon, S. H., & Griffin, L. D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00503-3 · Cited by 538
Silver, R. A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2864 · Cited by 481 · cited 1×
“In addition, changes in tonic inhibition can impact the sensitivity of a neuron to changes in inputs (the neuronal gain) by shunting the background synaptic noise (54, 88, 89) [but see (90) ].”
Extrasynaptic GABA A Receptors: Form, Pharmacology, and Function
Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., & Cope, D. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-09.2009 · Cited by 464 · cited 1×
“Neurosteroids are modulators of aminobutyric acid type A receptors (GABA A Rs) and can induce analgesic, anxiolytic, sedative, anesthetic, and anticonvulsant effects (4, 5) .”
Self-citationNeuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Rupprecht, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00064-1 · Cited by 427
Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone
Griffin, L. D., Gong, W., Verot, L., & Mellon, S. H. (2004) · Nature Medicine · doi:10.1038/nm1073 · Cited by 395
Bitran, D., Shiekh, M., & McLeod, M. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00744.x · Cited by 388
Activation of GABAA Receptors: Views from Outside the Synaptic Cleft
Glykys, J., & Mody, I. (2007) · Neuron · doi:10.1016/j.neuron.2007.11.002 · Cited by 358 · cited 1×
“Studies have demonstrated that ethanol enhances tonic GABAergic inhibition (154 – 156) likely via actions on GABA A R δ -subunit-containing receptors (157 – 159) .”
Sarkar, J., Wakefield, S., MacKenzie, G., Moss, S. J., & Maguire, J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2560-11.2011 · Cited by 254
Self-citationAnalysis of the set of GABAA receptor genes in the human genome
Simon, J., Wakimoto, H., Fujita, N., Lalande, M., & Barnard, E. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401354200 · Cited by 253 · cited 1×
“GABA A Rs are assembled from a combination of 19 sub-units ( α 1 – 6 , β 1 – 3 , γ 1 – 3 , δ , ε , θ , π , ρ 1 – 3 ) to form a heteropenta-meric structure around a central ion channel pore, which fluxes chloride (50 – 52) .”
Pinna, G., Costa, E., & Guidotti, A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0213-2 · Cited by 245 · cited 1×
“Antidepressant treatment normalizes the neurosteroid levels in depressed patients (106, 107, 112 – 114) , which is thought to mediate the antidepressant effects of these drugs (107, 113, 114) .”
Luisi, S., Petraglia, F., Benedetto, C., Nappi, R. E., Bernardi, F., Fadalti, M., Reis, F. M., Luisi, M., & Genazzani, A. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6675 · Cited by 237
Progesterone therapy in women with complex partial and secondary generalized seizures
Herzog, A. G. (1995) · Neurology · doi:10.1212/wnl.45.9.1660 · Cited by 218 · cited 2×
“Progesterone has been used as an add-on therapy for the treatment of catamenial epilepsy (144, 145) , with some success.”
Neurosteroid regulation of central nervous system development
Mellon, S. H. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.011 · Cited by 209
Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system
Compagnone, N. A., Bulfone, A., Rubenstein, J. L., & Mellon, S. H. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588260 · Cited by 201
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy
Reddy, D. S. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.02.017 · Cited by 167 · cited 2×
“Allopregnanolone is also found at low nanomolar concentrations in the plasma of both humans (32, 33) and rats (34 – 36) and fluctuates in response to stress (23, 36, 37) stage of menstrual/estrous cycle (32, 38) and pregnancy (33, 37, 39 – 41) , reflecting changes in peripheral progesterone levels.”
Lambert, J. J., Belelli, D., Harney, S. C., Peters, J. A., & Frenguelli, B. G. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00124-2 · Cited by 164
Pinna, G., Costa, E., & Guidotti, A. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.006 · Cited by 156 · cited 1×
“Antidepressant treatment normalizes the neurosteroid levels in depressed patients (106, 107, 112 – 114) , which is thought to mediate the antidepressant effects of these drugs (107, 113, 114) .”
GABAA receptor subtypes: the ‘one glass of wine’ receptors
Olsen, R. W., Hanchar, H. J., Meera, P., & Wallner, M. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.04.006 · Cited by 142
Liu, S., Sjövall, J., & Griffiths, W. J. (2003) · Analytical Chemistry · doi:10.1021/ac0346297 · Cited by 141 · cited 1×
“Although neurosteroid concentration measurements have been made in the central nervous system (CNS) of both rats (23, 35, 36, 42, 43) and humans (44 – 46) , accurately measuring neurosteroid concentrations is difficult and reflected in the range of neurosteroid concentrations reported in the literature.”
Liere, P., Pianos, A., Eychenne, B., Cambourg, A., Liu, S., Griffiths, W., Schumacher, M., Sjövall, J., & Baulieu, E.-E. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400244-jlr200 · Cited by 118 · cited 1×
“Although neurosteroid concentration measurements have been made in the central nervous system (CNS) of both rats (23, 35, 36, 42, 43) and humans (44 – 46) , accurately measuring neurosteroid concentrations is difficult and reflected in the range of neurosteroid concentrations reported in the literature.”
Chen, Z.-W., Manion, B., Townsend, R. R., Reichert, D. E., Covey, D. F., Steinbach, J. H., Sieghart, W., Fuchs, K., & Evers, A. S. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.078410 · Cited by 72
Tuveri, A., Paoletti, A. M., Orrù, M., Melis, G. B. B., Marotto, M. F., Zedda, P., Marrosu, F., Sogliano, C., Marra, C., Biggio, G., et al. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01555.x · Cited by 63 · cited 1×
“The basal THDOC concentration in the plasma of rats (26, 27) and humans (28, 29) is approximately ≤ 5 n m at rest.”
Neurosteroid influences on sensitivity to ethanol
Helms, C. M., Rossi, D. J., & Grant, K. A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00010 · Cited by 30 · cited 1×
“Because ethanol does not interfere with neurosteroid actions, it is thought to exert its actions on GABA A Rs via a site independent of the neurosteroid-binding site [for a review, see (153) ].”
Cited by
Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026
“Allopregnanolone is a GABAAR PAM, and acts on complexes containing most subunits, including synaptic (α, β, and γ) as well as the extrasynaptic δ that mediates tonic inhibition (MacKenzie and Maguire, 2013).”
BackgroundLee, V., & Maguire, J. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00003 · Cited by 228
Self-citationIs birth a critical period in the pathogenesis of autism spectrum disorders?
Ben-Ari, Y. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3956 · Cited by 117
MacKenzie, G., & Maguire, J. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3423-z · Cited by 84
“Further adding to the diversity of neurosteroid actions, GABA A Rs containing the ε subunit are relatively insensitive to neurosteroid actions (for a recent review, see Mackenzie and Maguire 2013).”
Self-citationFibromyalgia pathogenesis explained by a neuroendocrine multistable model
Demori, I., Losacco, S., Giordano, G., Mucci, V., Blanchini, F., & Burlando, B. (2024) · PLOS ONE · doi:10.1371/journal.pone.0303573 · Cited by 14
Metadata
- Authors
- MacKenzie, G., & Maguire, J.
- Venue
- bmc
- Publisher
- Walter de Gruyter GmbH
- Published
- 2012-11-16
- Volume
- 4
- Issue
- 1
- Pages
- 29-42
- ISSN
- 1868-5021 (ISSN-L)
- 1868-503X
- OpenAlex
- W2009719138
- Cited by
- 71
- References
- 30
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.